Clinical Trial Update: Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe (0653-070) [Phase 3]

View source ↗

Summary

This update documents the completion of a Phase 3 observational study evaluating the LDL-C lowering effect of ezetimibe in individuals with hypercholesterolemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED